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Abstract
 
After oral ingestion, 
 
Toxoplasma gondii
 
 crosses the intestinal epithelium, disseminates into the
deep tissues, and traverses biological barriers such as the placenta and the blood-brain barrier to
reach sites where it causes severe pathology. To examine the cellular basis of these processes,
migration of 
 
T. gondii
 
 was studied in vitro using polarized host cell monolayers and extracellu-
lar matrix. Transmigration required active parasite motility and the highly virulent type I strains
consistently exhibited a superior migratory capacity than the nonvirulent type II and type III
strains. Type I strain parasites also demonstrated a greater capacity for transmigration across
mouse intestine ex vivo, and directly penetrated into the lamina propria and vascular endothe-
lium. A subpopulation of virulent type I parasites exhibited a long distance migration (LDM)
phenotype in vitro, that was not expressed by nonvirulent type II and type III strains. Cloning
of parasites expressing the LDM phenotype resulted in substantial increase of migratory capacity
in vitro and in vivo
 
.
 
 The potential to up-regulate migratory capacity in 
 
T. gondii
 
 likely plays an
important role in establishing new infections and in dissemination upon reactivation of
chronic infections.
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Introduction
 
Toxoplasma gondii
 
 is an important opportunistic pathogen
causing disseminated congenital infections in the develop-
ing fetus (1), severe neurological complications in immu-
nocompromised individuals (2), and ocular pathology in
otherwise healthy individuals (3). Worldwide genotypic
analysis of 
 
T. gondii
 
 isolates has identified a population
structure consisting of three widespread clonal lineages,
termed type I, II, and III (4). Although type II strains have
a higher overall prevalence in human infections, type I
strains are over represented in studies of congenital toxo-
plasmosis (4, 5), and a perfect correlation between acute
virulence in mice and type I strains exists (6).
 
T. gondii
 
 is an obligate intracellular parasite of the phy-
lum Apicomplexa. It enters a wide range of host cells by
active penetration, a rapid process that is dependent on the
actin-myosin cytoskeleton of the parasite, and does not rely
on the host cell machinery for uptake (7, 8). Once inside
the host cell, the parasite resides in a vacuole that avoids fu-
sion with host cell endocytic and exocytic vesicular traffick-
ing pathways (9, 10). Apicomplexan parasites lack cilia or
flagella and their mode of locomotion, termed gliding mo-
tility, relies on the actin-myosin motor of the parasite (8).
Gliding motility also plays determinant roles in infections
by other apicomplexan that are important causative agents
of human and animal diseases, e.g., Plasmodium (11),
Cryptosporidium (12), and Eimeria (13).
In natural oral infections, Toxoplasma initially crosses
the intestinal epithelium, disseminates into the deep tissues,
and traverses biological barriers such as the placenta and the
blood-brain barrier to reach immunologically privileged
sites where it causes the most severe pathology. Histo-
pathological studies are consistent with invasion of a variety
of cell types in the intestine, including intra-epithelial leu-
kocytes (14), and with rapid hematogenous spread of para-
sites (15–17). Once in the circulation, it remains unknown
whether Toxoplasma disseminates as free, extracellular par-
asites or if it resides inside infected leukocytes, which are
permissive hosts that can cross many biological barriers.
Previous study of migration by Toxoplasma has relied on
gliding assays on coated surfaces in vitro (8) and focused on
the role of gliding motility for host cell invasion. The rapid
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spread of primary infections beyond the gut (15–17) led us
to hypothesize that this mode of locomotion plays a role in
another crucial step in infection, i.e., the ability to dissemi-
nate in the host by crossing nonpermissive biological barri-
ers
 
.
 
 Using in vitro and ex vivo models for migration, we
now demonstrate that 
 
T. gondii
 
 has substantial capacity to
cross epithelial barriers. Transmigration is correlated with
virulence and likely contributes to dissemination during in
vivo infections.
 
Materials and Methods
 
Parasites and Host Cell Lines.
 
Toxoplasma tachyzoites were
maintained by serial 2-d passage in human foreskin fibroblast
(HFF)
 
*
 
 cell monolayers as described previously (7). Parasite
strains used in this study include RH, RH-
 
lac
 
Z (8), PTG, and the
green fluorescent protein–expressing lines PTG-GFPS65T and
RH-GFPS65T, provided by Dr. K. Kim, Albert Einstein College
of Medicine, Bronx, NY (18). The various strains and clinical
isolates of genotype I, II, and III (4, 6) used in this study have
been deposited at the American Type Culture Collection. Viabil-
ity of parasites was determined by plaque formation on HFF
monolayers (19) and was defined as the ratio of the number of in-
tracellular replicating parasites/number of parasites inoculated.
Madin Darby Canine Kidney cells (MDCK, CCL-34) were ob-
tained from the American Type Culture Collection and cultured
according to guidelines.
 
Reagents and Antibodies.
 
Cytochalasin D was obtained from
Calbiochem. Low gelling temperature agarose was obtained from
Sigma-Aldrich. Matrigel
 
®
 
 was obtained from Becton Dickinson.
For detection of parasites in tissue sections and gliding trails,
polyclonal rabbit anti-toxoplasma tachyzoite serum or mAb
DG52 directly conjugated to Alexa 488 fluorophore (Molecular
Probes Inc.) were used. Goat anti–rabbit antibodies conjugated to
Alexa 488 or to Alexa 594 (Molecular Probes Inc.) were used as
secondary antibodies.
 
Migration Assays on HFF Monolayers Under Agarose.
 
Freshly
harvested parasites were plated onto HFF monolayers to yield an
infection density of 
 
 
 
1 infected HFF cell per 4 fields of vision
(
 
 
 
20). After 24 h, the monolayer was washed twice and the me-
dia substituted by 0.75% low-melting temperature agarose in
DMEM supplemented with 10% fetal calf serum, 2 mM
glutamine, and 20 
 
 
 
g/ml gentamicin. Assessment of migration
under agarose was performed 
 
 
 
18–24 h after egress of parasites
from the initial host cell to allow migration and invasion into
new host cells. The monolayers were examined using a ZEISS
Axioscope equipped for phase-contrast and epifluorescence mi-
croscopy. Foci were photographed randomly and distances mi-
grated by individual, intracellular replicating parasites were as-
sessed using image analysis software by measurement of the
shortest distance between the original focus of lysis (host cell) and
the intracellular parasites (Openlab, Improvision Inc.; and Adobe
Photoshop version 5.5, Adobe Systems Inc.).
 
Cloning by Micromanipulation.
 
Parasites migrating a distance
 
 
 
110 
 
 
 
m on HFF monolayers were cloned using micromanipu-
lation technique. Glass micropipettes (Stoelting) were stretched
to have a distal diameter of 25 
 
 
 
m and an Eppendorf Microman-
ipulator 1570 system and ZEISS Axioscope equipped for phase
 
contrast and epifluorescence microscopy were used. Individual
vacuoles containing intracellular replicating parasites located
 
 
 
110 
 
 
 
m from the original focus of egress were picked and
plated onto HFF monolayers in 96-well plates.
 
Transmigration Assays In Vitro.
 
MDCK cells were plated onto
24-well transwell filters (3 
 
 
 
m pore; Becton Dickinson) and
grown for at least 7 d to form a polarized monolayer (resistance
 
 
 
2,500 
 
 
 
/cm
 
2
 
 using an Ohmmeter; Millipore). Freshly egressed
parasites (0.5–1 
 
  
 
10
 
6
 
) were added to the upper well of the Trans-
well system and incubated at 37
 
 
 
C at indicated times. Alterna-
tively, a layer of 18–22 
 
 
 
m of Matrigel
 
®
 
 mixed with an equal
volume of DMEM supplemented with 10% fetal calf serum, 2
mM glutamine, and 20 
 
 
 
g/ml
 
 
 
gentamicin was added on top of
transwell filter and allowed to solidify. Transmigration of parasites
was quantified by colorimetric detection of 
 
 
 
-galactosidase activ-
ity immediately after incubation as described previously (8) or by
visual counting of parasite vacuoles, expressed as CFU in the
underlying HFF monolayer using epifluorescence microscopy
(green fluorescent protein [GFP]-transfected parasites) or phase-
contrast microscopy. Visual counting of vacuoles with intracellu-
lar replicating parasites was performed before lysis of the host
cells, i.e., 24 to 48 h after invasion. For inhibition of motility,
parasite suspensions were pretreated for 10 min at room tempera-
ture with 1 
 
 
 
M cytochalasin D and incubated in the presence of
1 
 
 
 
M cytochalasin D during the assay. For heat inactivation, par-
asites were incubated 30 min at 50
 
 
 
C before use.
 
Transmigration Assays Ex Vivo.
 
Adult female CD1 mice (Charles
River Laboratories) were used to obtain ileum that was exten-
sively washed and placed, lumenal side up, into a modified Ussing
2-chamber system. Both the mucosal and serosal reservoirs of the
chamber contained DMEM supplemented with 10% fetal calf se-
rum, 2 mM glutamine, and 20 
 
 
 
g/ml gentamicin (pH 7.4). The
buffer was gassed (21% O
 
2
 
–5% CO
 
2
 
) continuously during the ex-
periment and kept at 37
 
 
 
C. Parasites were introduced in the up-
per chamber and incubated at 37
 
 
 
C for 8 h. Samples were fixed in
3.7% formaldehyde in PBS, paraffin-embedded, and sections pro-
cessed for immunohistochemistry as described below. Penetration
of parasites to the different histological layers was assessed using
phase-contrast or epifluorescence microscopy by scoring parasites
in the epithelial cell layer and subepithelial cells layers including
the lamina propria, rich in connective tissue, and the submucosa,
where the post-capillary circulation is found. All protocols in-
volving animals were approved by the Animal Studies Commit-
tee of Washington University.
 
Immunohistochemistry.
 
Serial sections from mouse ileum were
deparaffinized, rehydrated, and exposed to primary antibody
(polyclonal rabbit anti-toxoplasma tachyzoite serum). Detection
was provided using a Vectastain Elite ABC HRP kit, visualized
by diaminobenzidine tetrahydrochloride (Vector Laboratories),
and counterstained with hematoxylin. In immunofluorescence
(IF) experiments, sections were exposed to a polyclonal rabbit
anti-toxoplasma serum or mouse mAb DG52 followed by goat
anti–rabbit conjugated to Alexa 594 or goat anti-mouse conju-
gated to FITC, respectively (Molecular Probes). Fluorescein-
conjugated Wheat Germ Agglutinin (Vector Laboratories) was
used as a surface cell marker when indicated, and nuclear stain-
ing was with 4
 
 
 
,6 diamidino-2-phenylindole (DAPI; Vector
Laboratories).
 
Parasite Dissemination In Vivo.
 
Adult female CD1 mice (Charles
River Laboratories) were challenged intra-peritoneally with 10
 
4
 
parasites. Parasite numbers in the spleen were determined as
described by Mordue et al. (20). Briefly, mice were killed and
the spleen was extracted and homogenized under conditions
 
*
 
Abbreviations used in this paper:
 
 DAPI, 4
 
 
 
,6 diamidino-2-phenylindole;
HFF, human foreskin fibroblast; IF, immunofluorescence; LDM, long
distance migration; MDCK, Madin Darby Canine Kidney. 
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that did not affect parasite viability. The number of viable
parasites in the tissue was determined by plaque formation on
HFF monolayers.
 
Gliding Assays.
 
Gliding assays were performed as described
(8). Briefly, glass chamber slides (Lab-Tek; Nunc) were coated by
incubation in 50% fetal bovine serum in PBS (pH 7.4) for 1 h at
37
 
 
 
C. Recently egressed parasites were added to the chamber
slides and incubated at 37
 
 
 
C for 30 min before fixation in 3.7%
formalin-PBS. Detection of trails was performed using mAb
DG52 directly conjugated to Alexa 488 fluorochrome. For time-
lapse video microscopy, parasites were allowed to glide on pre-
coated glass-bottom microwells and motion was recorded using a
ZEISS Axioscope, an ORCA-ER digital camera (Hamamatsu
Photonics), and image capture software Openlab version 3.02
(Improvision Inc.).
 
Statistical Analyses.
 
Statistical analyses were performed using
the Statistical Analysis Systems (SAS, version 8.1; SAS Institute).
 
Results
 
The Migratory Capacity of Toxoplasma on Host Cell Mono-
layers Is Strain Specific.
 
To determine the capacity of Toxo-
plasma to migrate away from a focus of infection, the
 
spread of parasites under soft agarose was measured in
vitro
 
.
 
 Quantitative differences were observed between the
ability of the virulent type I strain RH and the nonvirulent
type II strain PTG to migrate in this assay. While PTG
parasites always migrated 
 
 
 
70 
 
 
 
m, a small but reproduc-
ible subpopulation of the RH strain distinguished itself by
migrating 
 
 
 
50% further than the maximum distance ob-
served for PTG (i.e., 
 
 
 
110 
 
 
 
m; Fig. 1, A and B, and Ta-
ble I). Parasites exhibiting the long distance migration phe-
notype, termed LDM, were cloned by micromanipulation
(Fig. 1, B and B
 
 
 
, see arrows). When tested in the HFF
spreading assay, these clones generated exhibited a higher
frequency of LDM parasites, reaching levels 
 
 
 
20% of the
parasite population (Fig. 1, C and C
 
 
 
, and Table I). In
contrast, type II PTG parasites cloned from the periphery
of an infection focus (
 
 
 
70 
 
 
 
m migration) did not exhibit
increased migratory capacity, i.e., no parasites migrated
distances 
 
 
 
70 
 
 
 
m and no shift in the distribution of mi-
grated distances was observed (data not shown). Collec-
tively, these results show (a) important differences in mi-
gration exist between the type I strain RH and the type II
Figure 1. Characteristic migration patterns of the type I (RH) and the type II (PTG) strains and the LDM1 clonal line. Parasites were cultured on HFF
monolayers with an overlay of 0.75% agarose in culture medium as indicated in Materials and Methods. Migration was assessed 24 h after egress from the
original infected cell. Characteristic dispersion patterns of PTG strain (A) and RH strain (B, arrows indicate parasites migrating  110  m) and the clone
LDM1 (C), respectively. Scale bar   20  m. Type I (RH) parasites migrating  110  m were termed LDM and surpassed by  50% the longest migrated
distances by type II (PTG) parasites. Graphics show the relative distribution of migrated distances ( m) by different parasite populations calculated using
image analysis software as described in Materials and Methods (PTG [A ], n   306; RH [B ], n   296; LDM1 [C ], n   303). The y-axis indicates the
relative portion (%) of each category related to the total of the population examined. The distribution of distances migrated by individual parasites was
analyzed with the Shapiro-Wilk test of normality, showing that the PTG population approached a normal distribution (W   0.94; P   0.0001), whereas
RH (W   0.81; P   0.0001), and LDM1 (W   0.76; P   0.0001) were not normally distributed. 
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strain PTG, (b) the presence of at least two distinct popu-
lations with different migratory behavior in the type I
strain RH, and (c) migration can be up-regulated in the
virulent RH strain.
 
Transmigration of Toxoplasma Across Polarized Cell Mono-
layers and Extracellular Matrix Is Strain-specific and Requires
Active Motility.
 
During in vivo infections, Toxoplasma
crosses epithelial barriers by an unknown process. To ad-
dress the question whether Toxoplasma tachyzoites are ca-
pable of actively crossing cellular barriers, migration across
polarized MDCK cell monolayers or extracellular matrix
in a Transwell system was tested in vitro. Parasites readily
crossed the polarized monolayer in a time-dependent fash-
ion with type I strain RH being 10–100-fold more effec-
tive than type II strain PTG (Fig. 2, A and C, and Table I).
The increased migratory capacity of RH versus PTG was
confirmed using extracellular matrix (Matrigel
 
®
 
), where
transit also required active motility on the part of the para-
site (Fig. 2, C and D, and Table I). Transmigration across
MDCK monolayers was totally inhibited by heat inactiva-
 
Table I.
 
Migratory Characteristics of the Type I (RH) and Type II (PTG) T. gondii Strains and the LDM1 Clone
 
Migration away
from foci
Transmigration
across polarized
MDCK cells
Migration
through ECM
Gliding on
substrate Ex vivo penetration
Strain % 
 
  
 
110 
 
 
 
m
 
a
 
Parasites
traversing
 
b
 
Parasites
traversing
 
c
 
Mean
distance
 
d
 
Max
distance
 
e
 
% in
Lamina propria
 
f
 
% in
Submucosa
 
f
 
Type I (RH) 2.7 (1.2) 1.333 (0.211) 0.892 (0.245) 4.79 (0.30) 32 2.2 (1.18) 0.8 (0.38)
Type II (PTG) 0 (0) 0.025 (0.006) 0.062 (0.023) 1.56 (0.44) 9 0.38 (0.37) 0 (0)
LDM1 (RH clone) 22.1 (5.7) 3.14 (0.023) ND 5.36 (0.32) 33 ND ND
Values represent mean (
 
  SD) from three or four independent experiments. ND, not done.
aMean percentage of parasites migrating on HFF monolayers.
bMean number of parasites   10 3 penetrating MDCK monolayers.
cMean number of parasites   10 3 migrating across extracellular matrix (ECM).
dTrail lengths measured in number of parasite body lengths (5–7  m).
eTrail lengths measured in number of parasite body lengths (5–7  m).
fParasite penetration in mouse ileum ex vivo scored as percentage of the total population. The type I (RH) and the type II (PTG) strains exhibited
significant differences in penetration to the lamina propria (P   0.05, Student’s t test) and to the submucosa (P   0.005).
Figure 2. Transmigration across polarized
cell monolayers and extracellular matrix by
the type I strain (RH) and the type II strain
(PTG). Transmigration assays across polar-
ized MDCK monolayers (A and B) or
Matrigel® (C and D) were performed as in-
dicated in Materials and Methods. Quantifi-
cation was done by counting CFU (intra-
cellular vacuoles containing parasites) in an
underlying HFF monolayer (A and C) or by
colorimetric detection of  -galactosidase
( -gal) activity immediately after transmi-
gration using the parasite strain RH-lacZ (B
and D). Results are means from one repre-
sentative experiment done in triplicate. (A)
Kinetics of transmigration across polarized
MDCK cell monolayers revealed differences
between type I (RH) and type II (PTG)
strains. (B) Heat inactivation (Dead) of type
I (RH-lacZ) strain resulted in inhibition of
transmigration across polarized MDCK cell
monolayers. Parasite culture supernatant
was used as control. (C) Kinetics of transmi-
gration across matrigel® showed differences
between type I (RH) and type II (PTG)
strains. Transmigration was totally inhibited
in the presence of 1  M cytochalasin D (*).
(D) Inhibition of migration across Matrigel®
by 1  M cytochalasin D (CYT D). Parasite
culture supernatant was used as control.1629 Barragan and Sibley
tion of parasites (Fig. 2 B) and migration across extracellu-
lar matrix was blocked by cytochalasin D treatment (Fig.
2, C and D), indicating it depends on active motility by
the parasite.
Upregulation of Migration Also Enhances Traversal of Biologi-
cal Barriers. To examine whether increased migratory ca-
pacity of LDM-parasites on HFF monolayers would also
confer increased transmigratory capacity, LDM-clones
were assessed for their ability to cross-polarized monolay-
ers. For comparison, we analyzed a clone called LDM1
that had an enhanced capacity for long distance migration
on HFF monolayers where up to 20% of parasites mi-
grated  110  m from foci of infection (Fig. 3 A). The
LDM1 clone also exhibited an enhanced capacity to
traverse MDCK cell monolayers in vitro relative to the
type I RH strain from which it was derived (Fig. 3 B, and
Table I). As described above, the nonvirulent strain PTG
did not display a subpopulation of LDM parasites (Fig. 3
A), and showed significantly lower levels of transmigration
(Fig. 3 B). The differences in transmigration were not due
to differences in viability or infectivity between the
strains, which varied by  20% as shown by plaque forma-
tion on HFF monolayers (Fig. 3 C). We conclude from
these findings that (a) Toxoplasma is able to actively cross
polarized cell monolayers and extracellular matrix, (b)
these abilities are greatly enhanced in the virulent type I
(RH) strain, and (c) transmigratory capacity of type I
strains can be up-regulated.
Gliding Motility Features Are Conserved But Quantitative
Differences Exist Between Strains. To investigate whether
the difference in migration observed between strains was
due to differences in motility, the strains were compared
using well established gliding assays (8). Significant quanti-
tative differences in gliding distance were observed be-
tween the RH strain and the PTG strain (Fig. 3 D, and Ta-
ble I). Furthermore, the frequency of gliding parasites was
significantly higher for RH (1.3 trails/adhered parasite,
SD   0.20) than PTG (0.047 trails/adhered parasite, SD  
0.012). Time-lapse video microscopy of the PTG strain
confirmed that the three types of movement previously de-
scribed for gliding motility in RH, i.e. upright twirling,
circular and helical gliding, were present (data not shown).
Thus, the lower overall motility of PTG is not due to qual-
itative differences in motility. Importantly, the LDM1
clone was only slightly more motile in this in vitro assay
when compared with the RH strain (Fig. 3 D). Thus,
while the enhanced migration ability of type I strains may
be due to greater motility, this cannot account for the in-
crease in transmigration seen in LDM clones.
Ex Vivo Transmigration Is Strain Specific. During in vivo
infection, Toxoplasma crosses the intestinal epithelium to
lead to disseminated infection. The capacity of virulent and
nonvirulent strains to penetrate tissue was assessed using
mouse intestine in a modified Ussing two-chamber system.
Parasites readily invaded the intestinal mucosa, where a
majority of them ( 96%) took up residence in epithelial
cells (Fig. 4). However, significantly more type I strain RH
parasites penetrated into deeper tissue layers than type II
PTG parasites (Table I). RH parasites were more successful
in entering the lamina propria, penetrating the submucosa,
and in some cases were able to reach the vascular endothe-
lium (Fig. 4 D). The notable capacity for transmigration of
Figure 3. Invasion, motility, and migratory charac-
teristics of the RH (type I) and PTG (type II) strains
and the RH-derived clone LDM1. (A) Enhanced long
distance migration was observed in the LDM1 clone
vs. RH, but was absent in the PTG strain. Frequency
of parasites migrating  110  m (LDM) on an HFF
monolayer under agarose as indicated in Materials and
Methods. Results are mean (  SD) from three inde-
pendent experiments. (B) Significantly enhanced trans-
migration capacity was observed in the clone LDM1
vs. RH (P   0.005, Student’s t test). Frequency of par-
asites (  SD) transmigrating across polarized MDCK
cell monolayers was assessed as indicated in Materials
and Methods. (C) Plaquing assays on HFF monolayers
showed very similar viability for RH and LDM1, and a
slightly reduced viability for PTG. Plaquing assays were
evaluated at 5–7 d after inoculation and the number of
plaques generated was expressed as a percentage of par-
asites initially added. Average results are shown from
three independent experiments (  SD). (D) Gliding of
the RH strain was similar to that of the LDM1, but sig-
nificantly shorter trail lengths were observed for PTG
vs. RH (P   0.0005). Gliding trail lengths were mea-
sured as relative parasite body lengths (5–7  m) and the
average trail length from three independent experi-
ments (  SD) is shown.1630 Barrier Penetration by Toxoplasma
the RH strain thus enables the parasite to gain rapid transfer
across the intestinal epithelium.
Upregulation of Migratory Capacity Results in Faster Dissemi-
nation In Vivo. To investigate whether the differences in
migration observed between LDM clones and the parental
line RH, resulted in differences in dissemination during
acute infection, parasites were injected intraperitoneally
and the number of viable parasites in the spleen was moni-
tored daily. Both LDM1 and RH parasites were found in
the circulation and the spleen as early as 12 h after infection
(data not shown). Importantly, LDM1 parasites reached the
spleen in higher numbers shortly after the challenge, show-
ing more efficient dissemination at days 2 and 3 (Fig. 5).
Despite reaching the spleen more slowly the parental line
RH reached similar levels of parasite burden as LDM1
from day 4–5 after infection, suggesting the maximum level
of parasite growth is limited by host factors. The extreme
lethality of the parental line RH (LD100   1) precluded
analysis of differences in mortality. Nevertheless, it is clear
that upregulation of the LDM-phenotype results in more
rapid dissemination in vivo.
Type I Strains Exhibit a Superior Migratory Capacity Than
Type II and Type III Strains. T.  gondii strains are highly
clonal and distinct biological traits, such as virulence, are
characteristic of each clonal type. To investigate if our ob-
servations on differences in migration could be extended to
other type I, II, and III strains, 17 different strains and clin-
ical isolates were tested in migration assays. In every case,
type I strains showed significantly greater transmigration
than types II and III, crossing the barrier on average with
up to three orders of magnitude greater efficiency (Fig. 6).
Importantly, parasites migrating  110  m (LDM-pheno-
type) were only found in type I strains, extending our find-
ings on the RH strain to all type I strains tested. In contrast,
no type II or type III strain exhibited subpopulations of
parasites that migrated  110   m (LDM). Collectively,
these results demonstrate a strong association of the viru-
lence trait (type I strains) with increased migratory capacity.
Discussion
During in vivo infections, Toxoplasma crosses epithelial
barriers to gain access to deeper tissues including the brain,
the placenta and the retina. We now demonstrate that
Toxoplasma tachyzoites use active motility to cross polar-
ized cell layers and extracellular matrix. Using in vitro and
ex vivo systems that mimic biological barriers in vivo, we
show that the virulent type I strains consistently exhibit a
superior migratory capacity compared with the nonvirulent
type II and type III strains. The potential for this capacity
Figure 4. Ex vivo transmigration of T.
gondii (RH) across intestinal mucosa. Trans-
migration assays were performed on mouse
ileum in a modified Ussing 2-chamber sys-
tem as described in Materials and Methods.
(A) Section of distal villus from mouse il-
eum showing tachyzoites (red) invading ep-
ithelial cells. Immunohistochemistry was
performed with polyclonal rabbit anti-RH
serum and goat anti–rabbit antibody conju-
gated to Alexa 594. Epithelial cells were
counterstained with fluorescein-conjugated
wheat germ agglutinin and nuclear staining
was with DAPI. Scale bar   5  m. (B)
Close up of epithelial cell invasion by RH
tachyzoites (red). In the top part of the mi-
crograph is the apical side of the epithelial
cell layer and the lower part shows the limit
with the basal lamina (lamina propria). IF
was performed as in A. Scale bar   5  m.
(C and C ) Penetration of tachyzoites to
subepithelial cell layers in mouse ileum. (C)
Arrows indicate parasite vacuoles in the
lamina propria. IF was performed as in A.
Scale bar   5  m. (C ) Intracellular parasite
vacuoles were stained with diaminobenzi-
dine tetrahydrochloride as indicated in Ma-
terials and Methods. Epithelial cells were
counterstained with hematoxylin. Scale bar  
10  m. (D) Penetration of RH tachyzoites
(green) to the submucosa (white arrows) and
invasion of endothelial cells in the vascula-
ture (red arrow). IF was performed with
polyclonal rabbit anti-RH serum and goat
anti-rabbit antibody conjugated to Alexa 488.
Nuclear staining was with DAPI. Scale bar  
20  m.1631 Barragan and Sibley
to be up-regulated, and its association with virulence, sug-
gests that active parasite migration is an important compo-
nent of dissemination during toxoplasmosis
Our studies establish that (a) Toxoplasma is able to ac-
tively migrate across polarized cell monolayers and extra-
cellular matrix in vitro and across intestinal epithelium ex
vivo. Furthermore, we demonstrate that (b) type I strains
consistently exhibit a higher migratory capacity than type II
and III strains and that (c) the migratory capacity of the
highly virulent type I strain RH can be up-regulated. The
enhanced transmigration capacity of type I strains, which
was up to three orders of magnitude greater, could not be
explained by differences in viability or efficiency of inva-
sion. Furthermore, parasites with LDM-phenotype were
present in all type I strains tested but not in type II and III
strains. The migratory capacity of parasite populations was
easily up-regulated in the type I strain (RH) by selecting
parasites that migrated further.
Our findings demonstrate that active motility is not only
used for cell invasion but also provides the parasite with an
effective mechanism of dissemination in its microenviron-
ment within tissues. Moreover, ex vivo data indicates im-
portant differences in the ability to penetrate tissues, result-
ing in dramatic differences in the efficiency of reaching the
vascular endothelium. The ability to rapidly cross epithelial
barriers and reach the circulation may be an important
component of dissemination in vivo, particularly to sites of
immune privilege, e.g., the central nervous system and the
developing fetus.
Figure 5. Dissemination of RH (type I) and LDM1(RH clone) para-
sites in vivo. The number of viable parasites retrieved in the spleens of in-
fected mice is plotted separately and the means are indicated by the hori-
zontal bars. Parasite tissue burden was quantified daily after a challenge of
104 parasites intraperitoneally as indicated in Materials and Methods. Sig-
nificantly enhanced dissemination was observed in the clone LDM1 vs.
RH at day 2 after infection (P   0.005, Student’s t test) and at day 3 (P  
0.001), whereas, by day 4, differences in parasite load were nonsignificant
(P   0.05). The results shown are the mean of two independent experi-
ments consisting of three to four mice per time point.
Figure 6. Differences in transmi-
gration capacity between type I, type
II, and type III strains and expression
of the LDM-phenotype. Virulent and
nonvirulent parasite strains and clini-
cal isolates were classified by geno-
type as described (references 4 and 6).
Assessment for the LDM-phenotype
(parasite migration  110   m) was
performed on HFF cell monolayers
under agarose as indicated in Materi-
als and Methods. Graphics show ex-
pression ( ) of the LDM-phenotype
in all type I parasite lines tested and
absence ( ) of the LDM-phenotype
in type II and type III lines. Transmi-
gration of parasites across polarized
MDCK cell monolayers was assessed
by plaque formation (CFU) as de-
scribed in Materials and Methods.
The transmigration frequency for
each strain was calculated as the num-
ber of transmigrated parasites (CFU)/
1,000 parasites added and represents
the mean from three independent ex-
periments (  SD). Significant differ-
ences in frequency of transmigration
were observed between strains (P  
0.001 for type I vs. type II; P   
0.005 for type I vs. type III, Mann-
Whitney U-test) with transmigration
frequency differences superior to
three orders of magnitude (103).1632 Barrier Penetration by Toxoplasma
Traversal of biological barriers, including the intestine,
the blood-brain barrier and the placenta, leading to dissem-
ination within the host is a requisite for the establishment
of  T. gondii infections. Ingested parasites (oocysts and
bradyzoites in tissue cysts) invade the intestine and differen-
tiate into tachyzoites followed by spread of the organism
hematogenously and via lymphatics (15). Tachyzoites play
an important role in pathogenesis during acute toxoplas-
mosis (1, 3) and upon reactivation of chronic infections in
humans (21). Thus, our studies on the migratory character-
istics of Toxoplasma tachyzoites are directly relevant to the
role this stage plays in dissemination-related acute pathol-
ogy and in reactivation of chronic infections.
T. gondii has a highly unusual population structure com-
prised of three clonal lineages (I, II, and III) and the parasite
genotype influences the pathogenicity of the strain in mice
(4, 6). Type I strains have been associated to acute viru-
lence in the murine model and a relative over-representa-
tion of type I strains in congenital toxoplasmosis has been
described (4, 5). One key feature of infections by type I
strains in mice, is that they rapidly disseminate and reach
high tissue burdens even from a very low initial inoculum
(20, 22). The enhanced ability of type I strains to cross bio-
logical barriers likely represents an important advantage in
the establishment of disseminated infection.
The strong association of the LDM-phenotype and
transmigration efficiency with the parasite genotype I in-
dicates an underlying genetic basis controls this trait.
Nonetheless, the degree to which the LDM-phenotype is
expressed is clearly influenced by environmental factors as
it was up regulated in cloned populations (20%), but
waned again over a period of 20–21 infection cycles
( 160 mitotic cycles) in the absence of selection (data not
shown). LDM clones were also capable of faster migration
in vivo. After oral infection, it is possible that the ability
for deep tissue migration is up-regulated, for example by
selection for those parasites that successfully cross the in-
testinal epithelial barrier. Establishment of this early wave
of rapidly migrating parasites may be critically important
to dissemination of infection before the onset of an effec-
tive immune response.
Natural immunity against T. gondii is dependent on the
induction of strong parasite-specific immunity in the host
(23). Because neutrophils rapidly migrate to a site of infec-
tion, this initial response may be important for parasite
control before adaptive immunity is established (24, 25).
Toxoplasma actively infects leukocytes in vitro (26) and
tachyzoites have been identified within leukocytes in the
murine intestine (14). Thus, trafficking of leukocytes could
contribute to dissemination of intracellular parasites via a
Trojan horse type of mechanism (27, 28). However, the
present finding that Toxoplasma directly penetrates epithe-
lial monolayers and extracellular matrix indicates that mi-
gration across barriers may be primarily an active process.
Moreover, only active penetration by the parasite can ade-
quately explain transplacental infection, a common feature
of acute toxoplasmosis, as maternal cells do not routinely
traffic to the fetus. Enhanced migration by LDM parasites
was associated with a specific increase in transmigration and
not simply an overall increase in motility or invasion of
cells, suggesting that the parasite actively crosses biological
barriers using a specific pathway. Future investigations of
migration across endothelial and epithelial barriers will be
important to establish the mechanism of transit.
A number of invasive bacterial, viral and fungal micro-
organisms have been described to cross biological barriers
in the host and to cause disseminated infections. The pre-
cise mechanisms by which microbial pathogens gain entry
into the target tissue are only partly understood and in-
clude the induction of endocytosis/phagocytosis (29, 30)
or host actin-based translocation (31). In contrast, Toxo-
plasma, and other apicomplexans, actively penetrate their
host cells in vitro (8) and this process is also instrumental in
vivo. After subcutaneous injection by an infected mos-
quito, sporozoites of Plasmodium actively cross vascular en-
dothelium and Kupffer cells to reach hepatocytes where
they reside (32–36).
Toxoplasma establishes infection following oral inges-
tion, and consequently, to cause a systemic infection it
must cross the intestinal epithelium, basement membrane,
and lamina propria. Active traversal of cellular barriers rep-
resents a novel means of tissue dissemination used to gain
access to biologically restricted organs, e.g., the brain and
the placenta. We propose that the inherent property of vir-
ulent T. gondii type I strains to effectively migrate across
barriers and up regulate the migratory capacity is an impor-
tant component of pathogenesis in toxoplasmosis. Elucida-
tion of mechanisms underlying transmigration may lead to
the identification of important virulence factors in infec-
tions by T. gondii and other apicomplexan parasites.
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